- 专利标题： NOVEL SUBSTITUTED TETRAHYDROQUINOLIN COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS
-
申请号： US16758717申请日： 2018-10-29
-
公开(公告)号： US20210179607A1公开(公告)日： 2021-06-17
- 发明人: Yongqi Deng , Abdelghani Achab , Bridget A. Becker , David Jonathan Bennett , Indu Bharathan , Xavier Fradera , Craig Gibeau , Yongxin Han , Derun Li , Kun Liu , Qinglin Pu , Sulagna Sanyal , David Sloman , Wensheng Yu , Hongjun Zhang
- 申请人： Merck Sharp & Dohme Corp.
- 申请人地址： US NJ Rahway
- 专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人地址： US NJ Rahway
- 国际申请： PCT/US2018/057916 WO 20181029
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; C07D215/14 ; A61K45/06
摘要：
Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof (I). Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.
信息查询
